Literature DB >> 10346812

Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53.

H Nozawa1, E Oda, K Nakao, M Ishihara, S Ueda, T Yokochi, K Ogasawara, Y Nakatsuru, S Shimizu, Y Ohira, K Hioki, S Aizawa, T Ishikawa, M Katsuki, T Muto, T Taniguchi, N Tanaka.   

Abstract

The transcription factor IRF-1 has been implicated in tumor suppression: IRF-1 suppresses cell transformation and mediates apoptosis in vitro. Here we show that the loss of IRF-1 alleles per se has no effect on spontaneous tumor development in the mouse but dramatically exacerbates previous tumor predispositions caused by the c-Ha-ras transgene or by nullizygosity for p53. Grossly altered tumor spectrum, as compared to p53-null mice, was also observed in mice lacking both IRF-1 and p53, and cells from these mice show significantly higher mutation rate. Our results suggest that IRF-1 is a new member of the tumor susceptibility genes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346812      PMCID: PMC316726          DOI: 10.1101/gad.13.10.1240

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  39 in total

1.  Localization of the human chromosome 5q genes Gabra-1, Gabrg-2, Il-4, Il-5, and Irf-1 on mouse chromosome 11.

Authors:  M S Buckwalter; A C Lossie; L M Scarlett; S A Camper
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

2.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

3.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia.

Authors:  C L Willman; C E Sever; M G Pallavicini; H Harada; N Tanaka; M L Slovak; H Yamamoto; K Harada; T C Meeker; A F List
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

4.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

5.  Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes.

Authors:  A Saitoh; M Kimura; R Takahashi; M Yokoyama; T Nomura; M Izawa; T Sekiya; S Nishimura; M Katsuki
Journal:  Oncogene       Date:  1990-08       Impact factor: 9.867

6.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

7.  Chromosomal assignment of the murine gene encoding the transformation-related protein p53.

Authors:  V Rotter; D Wolf; D Pravtcheva; F H Ruddle
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

8.  Genetic resolution of susceptibility to cancer--new perspectives.

Authors:  P Demant
Journal:  Semin Cancer Biol       Date:  1992-06       Impact factor: 15.707

9.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.

Authors:  W F Dietrich; E S Lander; J S Smith; A R Moser; K A Gould; C Luongo; N Borenstein; W Dove
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

Authors:  T Kimura; K Nakayama; J Penninger; M Kitagawa; H Harada; T Matsuyama; N Tanaka; R Kamijo; J Vilcek; T W Mak
Journal:  Science       Date:  1994-06-24       Impact factor: 47.728

View more
  34 in total

1.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

2.  A murrel interferon regulatory factor-1: molecular characterization, gene expression and cell protection activity.

Authors:  Jesu Arockiaraj; Akila Sathyamoorthi; Venkatesh Kumaresan; Rajesh Palanisamy; Mukesh Kumar Chaurasia; Prasanth Bhatt; Annie J Gnanam; Mukesh Pasupuleti; Abirami Arasu
Journal:  Mol Biol Rep       Date:  2014-05-24       Impact factor: 2.316

Review 3.  The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis.

Authors:  B J Tura; K E Bunyan; D J Harrison
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

4.  Activation of IL-27 p28 gene transcription by interferon regulatory factor 8 in cooperation with interferon regulatory factor 1.

Authors:  Jidong Zhang; Xuesong Qian; Huan Ning; Jianjun Yang; Huabao Xiong; Jianguo Liu
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

5.  Anti-apoptotic effect by the suppression of IRF1 as a downstream of Wnt/β-catenin signaling in colorectal cancer cells.

Authors:  Tomoyuki Ohsugi; Kiyoshi Yamaguchi; Chi Zhu; Tsuneo Ikenoue; Kiyoko Takane; Masaru Shinozaki; Giichiro Tsurita; Hideaki Yano; Yoichi Furukawa
Journal:  Oncogene       Date:  2019-07-10       Impact factor: 9.867

Review 6.  Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.

Authors:  Marni S Crow; Krystal K Lum; Xinlei Sheng; Bokai Song; Ileana M Cristea
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

7.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

8.  Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL.

Authors:  Nicole Clarke; Ana M Jimenez-Lara; Emilie Voltz; Hinrich Gronemeyer
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

9.  CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.

Authors:  Aristides Moschonas; Maria Kouraki; Pauline G Knox; Efstathia Thymiakou; Dimitris Kardassis; Aristides G Eliopoulos
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

10.  Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer.

Authors:  Luciane R Cavalli; Rebecca B Riggins; Antai Wang; Robert Clarke; Bassem R Haddad
Journal:  Breast Cancer Res Treat       Date:  2009-08-21       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.